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Abstract
Background: Physicians, nurses and hospital pharmacists were surveyed to assess attitudes of hospital-based
pediatric caregivers regarding the dosing of medicine to children. Our objectives were to gauge how current
resources are utilized to guide the management of pediatric pharmacotherapy, assess drugs and drug classes
where guidance is most critical and examine the prevalence and practice of dose adjustment in pediatric patients.
Methods: Questionnaire categories included demographics, pharmacotherapy resources, dosing adjustment and
modification, and valuation of additional tools to provide improved pharmacotherapy guidance. The questionnaire
was developed in collaboration with representative nurse, pharmacist and physician team members using the
SurveyMonkey.com site and survey tool. The survey link was distributed to caregivers via email. The questionnaire
results of 303 respondents were collected into MS Excel and imported into SAS for data summarization.
Results: A total of 313 responses were obtained. Physician and nurse practitioner groups comprised the majority
of the responses. Approximately 80% of the responders considered dosing adjustment important in pediatric
pharmacotherapy. While there was general satisfaction with available resources, nearly 75% responded in support
of access to predictive tools that facilitate individualized patient pharmacotherapy. The majority of respondents
(> 65%) indicated that dosing outside standard practice occurs in 1-20% of their patients, while still a substantial
number of respondents (a range of 8 to 20% reflecting the resident and fellow categories) estimated between 20
and 50% of their patients required adjustments outside the standard practice.
Conclusions: Differences in prescribing habits based on caregiver role, specialty and location were small and likely
require further exploration. Existing resources are generally viewed as helpful but inadequate to guide
recommendations for individual patients. Decision support systems connected to hospital-based electronic medical
records offer the promise of informative and individualized pharmacotherapy guidance.
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Background
Children represent a dynamic target for prescribing phar-
macotherapy as age, size, organ function and develop-
mental state are factors that contribute to the variation in
drug response that limit the simplistic scale-down from
the adult “o n es i z ef i t sa l l ” dosing approach [1]. While
this concept is reasonably well appreciated by pediatric
caregivers, the extent to which this appreciation
translates into rationale dosing guidance in children is
unknown. Likewise, while prescribing to pediatric in-
patients is decidedly focused on the individual patient
with respect to dosing, this desire is often in conflict with
data generated by the drug sponsor where the resultant
prescribing information emphasizes the average or typical
patient, providing guidance to aggregate “special” popula-
tions. The introduction of new agents on formulary may
provide an improvement in clinical options but often
further complicates prescribing practice. In addition, pre-
scribing patterns change constantly and are not entirely
generalizable across institutions[2]. Many studies support
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poor adherence to evidence based treatment guidelines,
inadequate individual dosage adjustments and adverse
drug events [3-5].
Caregiver role is an important factor in the definition
of such patterns within an institution. While there is a
general workflow of order, verification and review shared
by the physician, nurse and pharmacist, the specific
checks and balances put in place to ensure accurate pre-
scribing and administration in an in-patient setting are
often unique to the subspeciality [6]. Johnson et al [7]
have previously examined the incidence of discrepancies
among written prescriptions, medication regimens and
patient discharge instructions sheets and the actual labels
on medications dispensed by community pharmacies.
The study documented prescriber errors in dosing fre-
quencies and formulations in addition to altered pre-
scriptions by the community pharmacists. The authors
called for improved education and risk management
efforts encouraging caregivers to consult appropriate
reference materials to ensure that dose formulations and
guidelines are accurate.
In fact, resources available to guide pediatric dosing are
few and the lack of resources well appreciated [8-10].
The most commonly appreciated resources include the
drug monograph or label (package insert) available in
paper and electronic forms and captured in compendia
guides such as the physician’s desk reference (PDR). The
source studies described in the package insert are typi-
cally limited to those conducted by or on behalf of the
drug sponsor but may also include literature studies sum-
marized by the drug sponsor. As the drug sponsor must
petition the FDA to include the proposed material in the
package insert, not all of the available information is
included in the drug monograph. Other compendia
sources such as the Lexi-Comp (http://www.lexi.com/) or
other pediatric dosing handbooks such as Harriet Lane
[11] attempt to review the relevant literature and provide
periodic updates. These are likely the best reflection of
current information regarding dosing guidance in pedia-
trics. However, there is often little interpretation and it is
challenging to synthesize the body of small discrete stu-
dies into a meaningful prescribing practice particularly
when the source studies are conducted for regulatory
purposes and not for informative dosing guidance. More
importantly, the format of this information is static and
text based. While on-line versions of Lexi-Comp and
other tools have made marked improvements with
respect to access and retrieval, it is still not in the scope
of the resource to interpolate, extrapolate or otherwise
summarize the information provided except through the
interpretation of the reader.
We have previously studied drug utilization patterns in
the pediatric ICU[12], developed visualization tools to
mine and query utilization patterns in the hospital in-
patient setting[13], developed a key performance index
(KPI) scoring system to rank and prioritize agents on for-
mulary for future study[14], and described how predictive
models can inform decision support system that interface
with the hospital’s electronic medical records (EMRs)
[15]. Our objective for this investigation was to assess
pediatric caregiver prescribing habits, including attitudes
with respect to their valuation of available resources to
guide pediatric pharmacotherapy. We were also inter-
ested in their opinions on dosing adjustments specifically
in the identification of agents difficult to manage, the fre-
quency of dosing modifications (beyond the standard of
care) in their practice and the factors they deem as criti-
cal criteria to guide such adjustments. The results of the
15-question survey were analyzed across caregiver role
and serve as the baseline assessment for the development
of decision support systems that will serve as a future,
dynamic resource to guide pediatric pharmacotherapy
with emphasis on individualized recommendations and
personalized, safe drug therapy.
Methods
Clinical Setting
The medical staff at The Children’s Hospital of Philadel-
phia (CHOP) includes approximately 900 Attending
Physicians, 223 Physician Fellows, 135 Physician Resi-
dents and 1900 Nurse Practitioners. These staff mem-
bers all have input into the prescribing decisions made
at CHOP. Additionally, there are 45 hospital pharma-
cists on staff with pharmacists having specialized roles
(clinical specialists) within therapeutic areas. Pharmacy
responds to drug information inquires ranging from
drug, dosage or dosage form recommendations to exten-
sive literature searches on specific pharmacotherapeutic
topics. The pharmacy service reviews all therapeutically
monitored drug concentrations reported by the clinical
laboratory twice daily. Medical staff is contacted with
recommendations if dosage adjustments are required.
Pharmacokinetics consultations are also provided upon
request of the medical staff.
The protocol for this investigation was approved by
the Institutional review Board of The Children’sH o s p i -
tal of Philadelphia. A waiver of HIPAA authorization
under 45 CFR 165.512(i)(2)(ii) was granted based on the
nature of the study evaluation. A waiver of assent and
parental permission and consent was also granted
because the study met the criteria under CFR 46.116(d),
due to its de-identified and retrospective design.
Questionnaire
A 15 question survey was prepared based on the feed-
back from a pilot questionnaire and specific comments
from each of the target caregiver roles (physician, nurse
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mately 30 pediatric caregivers and following interviews
with the questionnaire respondents, refined to the final
questionnaire. The final questionnaire was composed of
six tick-box questions, seven 3-4 point scale responses
(seven of which allowed comments) and 2 free text
questions; the actual questions and response options are
provided in the Appendix (see Additional file 1).
The survey of attending physicians, fellows, residents,
nurse practitioners, clinical pharmacists, physician assis-
tants and clinical nurse specialists was distributed
through the Survey Monkey (Portland, Oregon USA;
http://www.surveymonkey.com/) web-application via
internal email to approximately 900 pediatric caregivers
within the institution (926 was the actual number of
email recipients). The 4 domains surveyed included
demographics, pharmacotherapy resources, dosing
adjustment and modification, and valuation of additional
tools to provide improved pharmacotherapy guidance.
Questions considered the pediatric caregiver’s role, speci-
alty and location, as well assessing prescriber knowledge
regarding dosing guidance and attitudes toward dose
modification and patient individualization. The survey
also focused on accessibility, ease of use and appropriate-
ness of existing resources regarding pediatric dosing gui-
dance. Information regarding the frequency of dosing
modification along with consultation of dosing compen-
diums and estimation of success rate in dosing guidance
was acquired. The sampled population of caregivers was
largely based on the availability of mailing lists in which
the caregiver role could be assured. The greater represen-
tation of physicians from the in-patient setting likewise
reflects the fact that this population is collectively identi-
fied by group lists within the institution.
The responses were imported into SAS for further
summarization and analysis. Missing data values were
excluded from the frequency counts.
Results
Demographics
Surveys were distributed via email and up to 4 remin-
ders were issued over a 3 week period. A total of 313
completed surveys were received from the 926 targeted
caregivers. The 34% response rate does not reflect an
adjusted rate[16] based on acknowledged email receipt
and likely under-estimates the actual response which is
likely greater than 40% based on typical overestimation
of the denominator for email-based surveys[17]. Post
hoc analysis revealed that several caregivers within each
of the 4 email group lists targeted with either incorrectly
assigned or no longer at the institution; exact counts
were not confirmed. The distribution of caregiver roles
included 151 (48% of the total response) attending phy-
sicians, 69 (22%) nurse practitioners, 46 (15%) fellows,
37 (12%) residents, 6 (2%) clinical pharmacists, 3 (1%)
physician assistants and 1 (0.3%) clinical nurse specialist.
The last three categories were excluded from the analy-
sis summary due to the low response frequency (10
responses in total) leaving an evaluable dataset of 303
responses. Within the top five specializations, 65 were
from General Pediatrics, 37 from Neurology, 27 from
Oncology, 25 from Emergency Medicine and 22 from
Cardiology. As expected, the response rate for these spe-
cialties is correlated with their size. Figure 1 shows the
intersection of caregiver role and clinical specialty from
our surveyed population. Regarding location, 125 (83%)
of the attending physicians were located on the main
campus, 13 (9%) in specialty care centers and 12 (8%) in
primary care centers. In the nurse practitioner category,
57 (83%) were located on the main campus, 7 (10%) in
specialty care centers and 3 (4%) in primary care cen-
ters. For fellows, 45 (98%) were located in the main
campus setting and 1 (2%) in primary care centers. All
37 residents were located on the main campus.
Pharmacotherapy resources
The most common drug information resources cur-
rently available to the pediatric caregiver are summar-
ized in Table 1. With respect to the value attributed to
the existing resources, attending physicians and nurse
practitioners were split between ‘very’ and ‘somewhat’
informative while 63% of the fellows and 76% of the
residents described the available resources as ‘very
informative.’ Relatively few caregivers found the avail-
able resources to be ‘not very informative.’ Based on
the survey response, attending physicians preferred the
online Lexi-Comp system (77.5%), followed by past
experience (59%) and consultation with the hospital
pharmacist (53%). Fellows favored Lexi-Comp online
(87%), followed by hospital pharmacist consultation
(54%) and past experience (33%). Residents overwhel-
mingly preferred Lexi-Comp online (92%) but also
Sunrise Clinical Manager (51%) followed by the hospi-
tal pharmacist (46%). Nurse practitioners preferred
Lexi-Comp Online (83%) as well, followed by the hos-
pital pharmacist (45%) and past experience (45%). Dif-
ferences between physician classes likely reflect
prescribing frequency and experience as well as com-
fort with information technology.
Dosing adjustment and modification
Table 2 summarizes questionnaire responses that exam-
ined the attitudes of caregivers regarding dose adjust-
ment, the frequency they access existing resources and
the convenience and value they place on the guidance
they abstract from these resources. It is clear that
resources to support dosing guidance are viewed as
valuable. Approximately 80% of the respondents stated
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Page 3 of 9Allergy, Immunology, 
Infection
Cardiology
Emergency Medicine
Neurology
Oncology
Endocrinology
Pulmonary Medicine
Other 
General Pediatrics
Hematology 
Anesthesia
Gastroenterology
Pain Management
Child Development
Critical Care 
Rheumatology 
Adolescent Medicine
Otolaryngology 
AP: 65%
FP: 8% 
NP: 27% 
AP: 36%
FP: 36% 
NP: 28% 
AP: 59%
FP: 23%
NP: 18% 
AP: 57%
FP: 23% 
NP: 20% 
AP: 42%
FP: 33% 
NP: 25% 
AP: 37%
FP: 19% 
RP: 38%
AP: 75%
FP: 5%
NP: 20% 
AP: 72%
FP: 20%
NP: 8% 
AP: 43%
RP: 51%
NP: 6% 
Figure 1 Specialization of pediatric caregivers participating in a survey on valuation of pharmacotherapy resources and pediatric
prescribing habits at the Children’s Hospital of Philadelphia (n = 303). AP: Attending Physicians; FP: Physician Fellows; RP: Resident
Physicians; NP: Nurse Practitioners.
Table 1 Caregiver-identified preferences of sources for pediatric dosing guidance
Count (% of total in clinical role category)
Clinical
Roles
Physician’s
Desk
Reference
Lexi-Comp
Handbook
Harriet
Lane
Handbook
Sunrise
Clinical
Manager
Lexi-
Comp
Online
Scientific
Literature
Hospital
Pharmacist
Past
Experience
Epocrates Other
Attending
Physicians
42 (27.8) 43 (28.5) 44 (29.1) 31 (20.5) 117 (77.5) 62 (41.1) 80 (53) 89 (58.9) 19 (12.6) 39 (25.8)
Physician
Fellows
4 (8.7) 5 (10.9) 13 (28.3) 10 (21.7) 40 (87.0) 10 (21.7) 25 (54.3) 15 (32.6) 9 (19.6) 12 (26.1)
Resident
Physicians
- 7 (18.9) 10 (27.0) 19 (51.4) 34 (91.9) 3 (8.1) 17 (45.9) 6 (16.2) 5 (13.5) 6 (16.2)
Nurse
Practitioners
21 (30.4) 23 (33.3) 9 (13.0) 13 (18.8) 57 (82.6) 5 (7.2) 31 (44.9) 31 (44.9) 6 (8.79) 15 (21.7)
(Multiple selections permitted).
Glossary:
Physician’s Desk Reference: commercially published compilation of prescribing information on prescription drugs, updated annually.
Lexi-Comp: a pediatric-specific reference for pharmacotherapy guidance and drug formulary information (available in hardcopy and electronic formats; CHOP has
on-line version accessible from EMR system).
Harriet Lane Handbook: Reference for pediatric diagnostic and management guidance, recommended tests, therapeutic information, and comprehensive drug
formulary.
Sunrise Clinical Manager: an on-line patient data and lab ordering system.
Epocrates: medical software for drug interaction, drug prices, drug dosing and disease management.
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less than 25% of the time while 8 (residents) to 20% (fel-
lows) responded that this occurs between 25 and 50% of
the time. Not surprisingly, the majority (> 75%) of
pediatric caregivers rate dose adjustment as being ‘very
important’ with more than 20 rating it as ‘somewhat
important’. Regarding the convenience of obtaining dos-
ing guidance, most responded that the availability was
either somewhat or very convenient. The majority of
respondents indicated that dosing outside standard prac-
tice occurred in 1-20% of their patients, while still a
substantial number of respondents (a range of 8 to 20%
reflecting the resident and fellow categories)estimated
between 20 and 50% of their patients required adjust-
ments outside the standard practice. There was some
difference in the response rates by caregiver role for this
question, particularly between fellows and residents.
Valuation of additional prescribing tools
The value of tools that would provide individualized
dosing guidance was strongly endorsed by the question-
naire response with over 70% stating that these would
be desirable. Lack of user friendliness, error-proof guar-
antee and information on drug metabolism and pharma-
cokinetics-pharmacodynamics (PK-PD) were the highest
cited drawbacks of respondents. The next highest cited
complaints were inconsistent information, too popula-
tion-centric and too patient-centric at 15, 4 and 2% of
the total responses. Approximately 20% of those sur-
veyed felt that there were no drawbacks.
Dose modification outside the standard dose require-
ments while occurring infrequently (50-70% of the
pediatric caregivers modified dosages in only ‘1-20% of
patients’) reflects individual patient factors. As expected,
weight, organ function and age top the list of factors
Table 2 Prescribing practice, valuation of dose adjustment and pharmacotherapy guidance by caregiver role
% Response (within role)
Question Response Attending
Physician
Physician
Fellow
Resident
Physician
Nurse
Practitioner
Overall
Frequency of checking more than one source to obtaining
dosing guidance
Never 6 2.2 8.1 5.8 5.3
<25% of the
time
79.4 78.2 81.1 78.2 79.5
25-50% of the
time
12.6 19.6 8.1 14.5 13.6
>50% of the
time
2 0 2.7 1.5 1.7
Value of dosing adjustments in pediatrics Not very
important
2.7 0 0 1.4 1.7
Somewhat
Important
20.5 17.4 24.3 23.2 21.1
Very Important 76.8 82.6 75.7 75.4 77.2
Convenience of information on dosing guidance Not very
Convenient
7.9 8.7 2.7 8.7 7.6
Somewhat
Convenient
60.9 71.7 43.2 50.7 58.1
Very
Convenient
31.3 19.6 54.1 40.6 34.3
Frequency of patients requiring modification outside
“standard” dose recommendations
<1% of
patients
14 4.3 18.9 20.6 14.6
1-20% of
patients
66.7 73.9 73 52.9 65.4
20-50% of
patients
12.7 19.6 8.1 16.2 14.0
>50% of
patients
6 2.2 0 7.4 5.0
Other 0.7 0 0 2.9 1.0
Value of tools for individualized dosing guidance Yes 69.5 80.4 78.4 68.2 72.0
No 3.3 0 5.4 1.4 2.6
Maybe 27.2 19.6 16.2 30.4 25.4
(highest overall response per question in bold) (Response assessed as % category within caregiver role).
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(Appendix, Question 8, see Additional file 1). Body-
surface area and height were also cited although to a
lesser extent; these responses likely reflect specific drugs
and classes. Table 3 summarizes drug classes or indica-
tions identified as difficult to manage by clinical speci-
alty/setting. Overall, antibiotics (21%) are viewed as the
most complicated to manage, followed by anticonvul-
sants (18%) and anticoagulants (15.5%). The proximity
of these responses suggests that there is no real differ-
ence among caregivers between these drug classes.
Discussion
The results of this survey confirm the importance of
dosing guidance for the management of pediatric phar-
macotherapy among various caregiver roles and speciali-
zations. They also confirm the necessity of getting
feedback from this diverse community as there are dif-
ferences of opinion that can influence the acceptance of
new information and approaches as well as the imple-
mentation of new technology which offers the potential
to improve outcomes. This initial assessment was
designed to serve as a baseline response from the care-
giver community prior to the development, assessment
and hopefully future implementation of a pediatric
knowledgebase that provides real-time, individualized
guidance for dosing and managing drug therapy in
children.
Some obvious trends appear to reflect the seniority of
the caregiver. Specifically, the value placed on the scienti-
fic literature within the physician community would see-
mingly correlate with age and experience with 41.1, 21.7
and 8.1% of attendings, fellows and residents respectively
responding that they refer to the scientific literature for
dosing guidance. It may also reflect the time that each of
these roles has to devote to searching and reviewing the
literature. Likewise, it is not surprising that only 16% of
the residents cite ‘past experience’ as a resource for phar-
macotherapy guidance. Perhaps consistent with their
generation, residents would seemingly be more comforta-
ble with information technology as 92% refer to Lexi-
Comp Online and 51% use Sunrise Clinical Manager
(the EMR system; as opposed to ~20% for the other
responders).
Compared to 51% of the attending physician commu-
nity and 48% of the nurse practitioners, over 75% of the
residents categorize compendial information to be “very
informative.” It may also suggest that the surveyed
attending physicians and nurse practitioners are generally
more experienced and hence less dependent on such
compendiums. Residents and nurse practitioners have
similar responses throughout which may be due to the
fact that they are responsible for most of the actual
ordering in the hospital. It is interesting to note that 81%
of the residents use SCM compared to attendings (33%),
fellows (39%) and nurse practitioners (30%). As residents
are extensively engaged in ordering and prescribing,
which is primarily accomplished through SCM at the
moment, this is also not surprising. It was somewhat sur-
prising that antibiotics were identified as a difficult to
manage drug class given that there is generally more
data/experience with this class than others. This likely
reflects the diversity in specialty and experience as well.
Hence, age, experience, specialty and role of the pedia-
tric caregiver appear to be key factors underlying differ-
ences in how individual caregivers respond to clinical
decisions regarding dosing children as well as educate
themselves with available resources to further guide
them[18]. While technologic advances such as Compu-
terized Physician Order Entry (CPOE) systems have the
potential to greatly reduce human error, their actual
performance is highly variable[19,20]. It has been main-
tained that the strategy for preventing errors and
adverse events in health care must involve tools that can
Table 3 Medication classes identified as difficult to manage+ (303 evaluable respondents*)
Rank Classes/Agents Cited within Specialty
Allergy and
Immunology; Infectious
Disease
Cardiology Emergency Medicine General
Pediatrics
Neurology Oncology
1 Antibiotic, Antifungal Anticoagulant Antibiotics, Anticonvulsant,
Antiemetic
Anticonvulsant Anticonvulsant Antineoplastic
2 Antiviral Antiarrhythmic Antianxiety, Antiarrhythmic,
CNS Agents
Antibiotic Antibiotics,
Anticoagulant
Anticonvulsant,
Orphan Drug
3 Anti-infective, Asthma Antihypertensive,
Immunosuppressant
Antidepressants,
Immunosuppressant
ADHD Antiarrhythmic,
CNS Agents
Anticoagulant,
Antifungal
4 Antihistamine Antibiotic ADHD, Antihypertensive,
Antineoplastic
Antidepressant,
CNS Agents
Antihypertensive Antianxiety,
Antidepressant
5 AIDS,
Immunosuppressant
Anti-anxiety, Anticonvulsant,
CNS Agents, Orphan Drugs
Anticoagulant, Antifungal,
Anti-infective, Orphan Drugs
Anticoagulant,
Antifungal
Antifungal,
Orphan Drugs
ADHD
*Note: Responses pooled across caregiver role.
+ Tied ranks listed based on equivalent respondent counts.
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accessible, require key pieces of information, assist
with calculations, perform checks in real-time, assist
with monitoring and provide decision support[21]. This
functionality is currently unavailable at many pediatric
in-patient centers. Hence, satisfaction with existing
resources should not prevent the construction and
deployment of tools that enhance patient safety and pro-
vide confidence to caregivers with respect to managing
their patient’s drug therapy. Most importantly, it is clear
that this community must be continually engaged to
ensure that new technology is properly scrutinized and
evaluated prior to and during implementation.
Given the diversity in experience and specialization of
the pediatric caregiver community, it seems obvious that
drug and disease-specific guidance with reference to the
individual patient would facilitate more standard prac-
tices around dosing adjustments and raise the overall
knowledge on pediatric clinical pharmacology and thera-
peutics. This is especially relevant given the concerns
about the adequacy of training in pediatric clinical phar-
macology and toxicology[5,22-25]. The prevalence of
EMR systems among our various pediatric in-patient
and out-patient facilities would seem to be a perfect
conduit for this information[26] although the task and
scope for such a medical informatics system is, as yet, in
i t si n f a n c y .I ti sc l e a rt h a tthe successful development
and support for such a system will have to be shared
among the various stakeholders and accommodate the
requirements from a diverse caregiver community.
These results indicate several limitations with the survey
which must be appreciated. First and foremost, it is based
on a single institution and the generalizability of these
results must consider potential regional differences in pre-
scribing practices as well as differences due to setting (i.e.,
smaller community-based institutions). Secondly, while
efforts were made to ensure a balanced response with
respect to caregiver roles and location, we were somewhat
limited by the availability of mailing lists that could accu-
rately identify roles as well as caregivers in specialty cen-
ters. These were not easily assembled at the time of the
survey due, in part, to an antiquated email system that has
since been replaced. Finally, the categorical responses
defined in the survey questions, while based on the expert
opinion of our design group (and reflecting the caregiver
community) seemingly lacks the granularity to provide
more quantitative point estimates for certain questions.
Despite these limitations, we feel the results are robust cer-
tainly for our institution and similar large, teaching hospi-
tals in which the care of children is the primary emphasis.
Sjoborg[27] previously reported pilot results from a
computerized prescribing system that provides pharma-
cological knowledge at the point of care. Their approach
focused on providing recommendations, alerts for
interaction, drug therapy during pregnancy and breast
feeding and a search tool for adverse effects through a
single database interfaced to their hospital’s EMR system.
Recognizing the time limitations often presented to our
pediatric caregivers, their results would seem to support
the proof of concept for this approach. Most importantly,
the authors call for a more coordinated effort within and
across countries as opposed to the home grown efforts at
various academic medical centers[15,28]. Our results
would seem to support this finding and suggest further
that more dynamic integration of decision analytics to
hospital EMRs will also enhance such a knowledgebase
[15]. It is also clear that the involvement of the varied
caregivers involved in managing drug therapy to children
will be essential to ensure that differences in role, speci-
alty, and function are accommodated in both the design
and testing of such systems and tools.
Conclusions
Deriving optimal dosing guidance for children continues
to be a concern for pediatric caregivers[29]. The amount
of information available for dosing guidance in children,
while still inadequate, is more vast and complex than in
the past[8]. With the necessity of modifying dose based
on age, weight, developmental status, organ function,
drug interaction potential and other disease-modifying
conditions looming, integrated solutions that synthesize
this information should provide more informed decision
making. In the past there may have been concerns with
physician willingness to trust and utilize such systems
[30]. With the continued exposure to information tech-
nologies, it is obvious that these concerns are lessening
and will eventually be irrelevant[31]. As others have
pointed out, the support of new technologies by enligh-
tened leadership will be a critical aspect in the transition
to new technologies. It is clear that being satisfied with
the status quo benefits neither the quality of clinical deci-
sion making nor the care of our patients. Additional
resources to guide pediatric pharmacotherapy are needed
now and must be based on the currently available knowl-
edge regarding the drug-disease-population interface.
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